Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Palliative Care Research ; : 17-22, 2022.
Article in Japanese | WPRIM | ID: wpr-924571

ABSTRACT

We here report three cases of choroidal metastases with ocular pain and visual symptoms treated with palliative irradiation. Case 1: A 71-year-old woman was treated with chemotherapy for multiple metastases after surgery for right breast cancer. Sixteen years after surgery, a right choroidal metastasis with ocular pain and visual disturbance was detected. Palliative irradiation to this lesion achieved reduction in ocular pain and shrank the tumor. Case 2: A 54-year-old man presented with right ocular pain and abnormal vision and was diagnosed as having right lung cancer with multiple systemic metastases. Palliative irradiation to a right choroidal metastasis achieved reduction in ocular pain and shrank the tumor. Case 3: A 71-year-old woman developed left eye pain 17 months after surgery for lung cancer in the right upper lobe. She was diagnosed as having a left choroidal metastasis. After palliative irradiation, the tumor shrank and the left eye pain temporarily resolved. Palliative radiation therapy for choroidal metastasis with ocular pain and visual symptoms seems to be effective in improving symptoms.

2.
Chinese Journal of Ultrasonography ; (12): 563-568, 2021.
Article in Chinese | WPRIM | ID: wpr-910092

ABSTRACT

Objective:To analyze the perfusion characteristics of choroidal metastasis using contrast-enhanced ultrasound, and compare with choroidal hemangioma.Methods:This was a retrospective study.From January 2016 to February 2018 in Beijing Tongren Hospital, a total of 21 eyes from 21 patients who were clinically diagnosed as choroidal metastasis were included as the choroidal metastasis group and 46 eyes from 46 patients who were diagnosed as choroidal hemangioma during the same period were included as the choroidal hemangioma group. All patients underwent contrast-enhanced ultrasound examination, and Sonoliver was used to obtain the data on quantitative parameters of the tumor and the adjacent normal orbital tissues, including maximum of intensity (IMAX), rise time (RT), time to peak (TTP), and mean transit time (mTT). The quantitative parameters between choroidal metastasis and normal orbital tissues were compared. And the quantitative parameters between choroidal metastasis and choroidal hemangioma were compared. The receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance.Results:The IMAX of choroidal metastasis was significantly higher than that of normal orbital tissues, while RT, TTP and mTT were significantly shorter than these of normal orbital tissues (all P<0.01). The IMAX of choroidal metastasis was lower than that of choroidal hemangioma, and RT, TTP and mTT were shorter than choroidal hemangioma (all P<0.01). The ROC curve analysis showed that area under curves of the IMAX, RT, TTP and mTT were 0.775 (95% CI=0.666-0.884), 0.970 (95% CI=0.896-0.996), 0.729 (95% CI=0.607-0.831) and 0.992 (95% CI=0.931-1.000) respectively. The sensitivities were 71.7%, 95.7%, 76.1% and 95.7%, and the specificities were 85.7%, 90.5%, 66.7% and 95.2%, respectively. Conclusions:Contrast-enhanced ultrasound can reflect the differences in perfusion characteristics between choroidal metastasis and choroidal hemangioma. RT and mTT are useful parameters in differential diagnosis between the two types of tumors.

3.
Rev. Soc. Colomb. Oftalmol ; 53(1): 44-50, 2020. ilus.
Article in Spanish | LILACS, COLNAL | ID: biblio-1128158

ABSTRACT

Introducción: se presenta el caso de un paciente de 36 años, a quien se le realizó el diagnostico de tuberculoma coroideo, otorgando tratamiento sin mejoría de los síntomas. Posteriormente fallece dilucidándose el diagnóstico de adenocarcinoma de pulmón con metástasis a coroides. Objetivo: informar el diagnóstico de metástasis coroidea como manifestación inicial, de adenocarcinoma de pulmón, en un paciente joven. Diseño de estudio: reporte de caso. Resumen del caso: masculino de 36 años de edad, antecedente de tuberculosis en la infancia, tabaquismo positivo no significativo. Presenta baja visual de ojo derecho, siendo diagnosticado con tuberculoma coroideo, asociado a sudoración nocturna, lumbalgia, tos y QuantiFERON-TB positivo. Se inicia tratamiento antituberculosis. Posterior, presenta deterioro respiratorio y neurológico requiriendo intubación orotraqueal, ulteriormente fallece. La autopsia elucida el diagnóstico de adenocarcinoma de pulmón con metástasis a coroides, hígado y riñón. Conclusión: las metástasis coroideas conllevan un mal pronóstico visual y sistémico, se requiere un alto índice de sospecha en pacientes menores de 50 años sin factores de riesgo. Se convierten en un reto diagnóstico, sobre todo en países donde predominan las enfermedades infecciosas. El papel del oftalmólogo es realizar el diagnóstico oportuno y correcto, evitando así retrasar el tratamiento.


Background: the case of a 36 year-old patient is presented, who was diagnosed with choroidal tuberculoma, giving treatment without improvement. Then, the diagnosis of pulmonary adenocarcinoma and choroidal metastases was elucidated. Objective: to report the diagnosis of metastasis as the initial manifestation of lung adenocarcinoma in a young patient. Study design: case report. Case summary: male, 36 years old, history of tuberculosis in childhood, positive smoking, but not significant. He presented visual loss of the right eye, being diagnosed with a choroidal tuberculoma, associated with night sweats, cough and positive QuantiFERON-TB test, treatment for tuberculosis was initiated. Later he had respiratory and neurological deterioration requiring orotracheal intubation, but unfortunately he died. Autopsy reveals lung adenocarcinoma with choroidal, liver and kidney metastases. Conclusion: choroidal metastases lead to poor visual and systemic prognosis, a high suspicion is required in patients under 50 years of age without risk factors. They become a diagnostic challenge, especially in countries where infectious diseases are predominat. The ophthalmologist's role is to make the diagnosis timely and correctly, thus avoiding delaying treatment.


Subject(s)
Choroid Neoplasms , Tuberculosis , Tuberculosis, Ocular , Adenocarcinoma of Lung , Neoplasm Metastasis
4.
Indian J Ophthalmol ; 2018 Aug; 66(8): 1215-1217
Article | IMSEAR | ID: sea-196853

ABSTRACT

Choroid metastasis from esophageal carcinoma is rare; reports addressing the effectiveness of treatment strategies are limited. We report a case of a 51-year-old man with metastatic esophageal carcinoma who had a 1-month history of blurred vision in his left eye. An ophthalmologic examination revealed a choroidal mass in his left eye. Adjuvant chemotherapy with cisplatin and 5-fluorouracil was initiated; however, visual acuity did not improve. External beam radiotherapy (EBRT) was initiated, resulting in near complete regression of the mass. EBRT is an effective therapeutic modality and should be considered in patients with choroidal metastasis of esophageal carcinoma.

5.
Journal of the Korean Ophthalmological Society ; : 106-112, 2017.
Article in Korean | WPRIM | ID: wpr-56574

ABSTRACT

PURPOSE: To report a case of choroidal metastasis caused by lung cancer in a young female who had no history. CASE SUMMARY: A 31-year-old female presented with decreased vision for 1 week. Fundus examination revealed an orange colored choroidal tumor and serous retinal detachment at superotemporal area of the optic disc on the left eye. On chest X-ray, atypical pneumonia or hematogenous metastasis was shown. Additionally, mammography, chest-abdomen computed tomography, lumbar magnetic resonance imaging, and transbronchial lung biopsy were performed and the patient was finally diagnosed with adenocarcinoma. The patient started systemic chemotherapy and visual acuity improved after 1 month. Tumor size and subretinal fluid also decreased. The tumor disappeared 2 months later and there was no recurrence. CONCLUSIONS: There are only few cases in which choroidal metastasis was observed in a young female patient with no history who had decreased visual acuity and was later diagnosed with lung cancer. Authors report this case because a satisfactory result was obtained from chemotherapy alone.


Subject(s)
Adult , Female , Humans , Adenocarcinoma , Biopsy , Choroid , Citrus sinensis , Drug Therapy , Lung Neoplasms , Lung , Magnetic Resonance Imaging , Mammography , Neoplasm Metastasis , Pneumonia , Recurrence , Retinal Detachment , Subretinal Fluid , Thorax , Visual Acuity
6.
International Eye Science ; (12): 1216-1220, 2016.
Article in Chinese | WPRIM | ID: wpr-637800

ABSTRACT

Choroidal metastasis is one of the most common malignant tumors inside the eyes. It causes pain, hypopsia and some other related symptoms. It reduces the quality of the patients' life. It's significant for the patients to be detected and treated early, therefore they will have better vision and longer life. The treatments of choroidal metastasis are developing quickly. Both the vitreous cavity injection of targeted drug and gene therapy are hot topics of research. This paper summarizes the etiology, development, diagnosis and treatment of choroidal metastasis nowadays.

7.
Indian J Ophthalmol ; 2015 Aug; 63(8): 674-678
Article in English | IMSEAR | ID: sea-170434

ABSTRACT

Cervical cancer is the most common cancer among females in India. Cervical cancer usually spreads by local extension and through the lymphatic drainage to the lymph nodes. Hematogenous spread, the mechanism responsible for distant metastases, is rarely seen in cervical malignancies. In this communication, we report a case of a 45-year-old woman who presented with unilateral decrease in vision of 3 months duration. She was found to have a serous retinal detachment with underlying diffuse, subretinal yellowish-cream colored infiltrates in the right eye, suspicious of choroidal metastases. Systemic evaluation showed disseminated systemic metastases arising from a primary adenocarcinoma of the cervix. In this communication, we review all the documented cases of metastases to the eye and adnexa arising from cervical cancer and their clinical characteristics. Unilateral choroidal metastasis arising from an adenocarcinoma of the cervix is extremely rare with only one previous documented case. Although uncommon, choroidal metastasis may be the presenting feature of primary cervical malignancy. Furthermore, cervical malignancy must be ruled out in women who present with orbital or choroidal metastases arising from unknown primary.

8.
Rev. cuba. oftalmol ; 25(1): 161-168, ene.-jun. 2012.
Article in Spanish | LILACS | ID: lil-629500

ABSTRACT

Se presenta una paciente de 55 años de edad con diagnóstico de carcinoma ductal infiltrante grado II multicéntrico de mama izquierda. Esta refiere pérdida del hemicampo temporal del ojo izquierdo. A través de la oftalmoscopia binocular indirecta se le diagnosticó una lesión metastásica coroidea y se corroboró por ultrasonido ocular. Se le realizó tratamiento quirúrgico del tumor primario, además de poliquimioterapia, terapia hormonal y radioterapia local externa a la lesión coroidea. A los seis meses de tratamiento hubo regresión total de la lesión con recuperación de la visión a 20/20, valor inicial al diagnóstico de la enfermedad.


The case of a 55-year-old woman with diagnosis of multinodular Grade II ductal infiltrating carcinoma in left breast was presented in this article. She presented with temporal visual field defect in her left eye. A choroidal metastatic tumor was diagnosed by indirect binocular ophthalmoscopy, confirmed by ocular echography. The primary tumor was removed by surgery and the choroidal lesion was treated with systemic chemotherapy, hormonal therapy and external beam radiation therapy. Six months after the treatment, the choroidal metastasis showed complete regression, and the best visual acuity of 20/20 was recovered, which was the initial value at the diagnosis of disease.

9.
Journal of the Korean Ophthalmological Society ; : 880-885, 2012.
Article in Korean | WPRIM | ID: wpr-45158

ABSTRACT

PURPOSE: To report a rare case of choroidal metastasis from renal cell carcinoma. CASE SUMMARY: A 61-year-old man visited our clinic with the chief complaint of decreased vision in the right eye. Three years earlier, he underwent right nephrectomy due to renal cell carcinoma. Best corrected visual acuity was 0.2 in the right eye and 1.0 in the left eye. Fundoscopic examination of the right eye revealed a yellowish, dome-shaped elevated choroidal mass with serous retinal detachment, measuring 5.0 x 4.0 disc diameter and located lateral to the macular area. Systemic evaluations showed multiple lung and brain metastases. A diagnosis of choroidal metastasis from renal cell carcinoma was made for the right eye, and the patient received local treatments with oral sorafenib therapy, composed of subtenon triamcinolone injection and intravitreal ranibizumab injection. Tumor progression continued, and visual acuity declined to hand motion. Enucleation was recommended, but the patient refused and is on a regular follow-up after transpupillary thermotherapy. CONCLUSIONS: Ocular manifestation may be the initial presenting sign of a recurrent tumor, and an extensive systemic evaluation for metastatic malignancy should be performed. The present example showed a rare case of choroidal metastasis from renal cell carcinoma.


Subject(s)
Humans , Middle Aged , Antibodies, Monoclonal, Humanized , Brain , Carcinoma, Renal Cell , Choroid , Eye , Follow-Up Studies , Hand , Lung , Neoplasm Metastasis , Nephrectomy , Niacinamide , Phenylurea Compounds , Retinal Detachment , Triamcinolone , Vision, Ocular , Visual Acuity , Ranibizumab
10.
Soonchunhyang Medical Science ; : 111-114, 2012.
Article in English | WPRIM | ID: wpr-73333

ABSTRACT

A 56-year-old female patient presented with decreased visual acuity in her right eye lasting for one day. During the first visit, best corrected visual acuity (BCVA) was 20/80 and 20/20, in the right and left eye, respectively. Fundus examination of the right eye revealed an elevated mass in the superior area of the optic disc and exudative retinal detachment in the macula. Choroidal metastatic tumor secondary to non-small-cell lung cancer (NSCLC) was diagnosed after systemic work up. Photodynamic therapy (PDT) and the intravitreal bevacizumab injection for choroidal metastatic carcinoma were performed. After six months, the BCVA of the right eye was improved to 20/25. Complete regression of the tumor was noticed and serous detachment was resolved. There has been no recurrence for six months. We observed that combined treatment with PDT and intravitreal bevacizumab injection is effective in BCVA improvement and tumor regression, in a patient with choroidal metastasis of NSCLC.


Subject(s)
Female , Humans , Antibodies, Monoclonal, Humanized , Choroid , Eye , Lung , Lung Neoplasms , Neoplasm Metastasis , Photochemotherapy , Recurrence , Retinal Detachment , Triazenes , Visual Acuity , Bevacizumab
11.
International Eye Science ; (12): 609-612, 2007.
Article in Chinese | WPRIM | ID: wpr-641691

ABSTRACT

AIM: To report the usefulness of a new parameter (maximum cross sectional area) in the measurements of B-scan ultrasonography to evaluate the progress of choroidal metastatic tumour size during the follow-up of patient.METHODS: Case report-the B-scan ultrasonographic measurements of height, base and maximum cross sectional area during the follow-up of the patient are presented.RESULTS: A 62-year-old Chinese lady, known case of non-small cell lung carcinoma, presented with painless blurring of vision in the right eye. She was diagnosed to have bilateral choroidal metastasis (advanced in the right eye and early in the left eye) with good vision in both eyes. The tumour size in the right eye reduced significantly after the first chemotherapy; but increased again 6 weeks after the end of last cycle of chemotherapy. She was given radiotherapy and another course of chemotherapy. The tumour size in the right eye did not respond much later on. However, the tumour size in the left eye was static through out the follow up period of 2years. The patient maintained best corrected visual acuity in both eyes (6/9 in right eye and 6/6 in left eye). The progress of tumour size in right eye was evaluated with serial B-scan ultrasonographic measurements.CONCLUSION: The ultrasonographic measurements were reproducible all through the follow up period and coincided well with clinical appearance of the tumour in right eye. We suggest the use of B-scan ultrasonography in the follow up of patients with elevated choroidal masses for quantitative assessment of progression/regression in their size during the treatment period.

12.
Korean Journal of Pathology ; : 471-473, 1999.
Article in Korean | WPRIM | ID: wpr-226633

ABSTRACT

Choroidal metastatic carcinoma is very rare. We recently experienced a case of lung adenocarcinoma which presented to the clinic with ocular symptoms. This 57-year-old Korean male patient visited the department of ophthalmology due to decreased visual acuity and pain of the left eye. On MRI scan, a nodule was attached to the retina of the left eyeball. On simple chest radiograph, a large amount of pleural effusion was noted in the left pleural cavity. Emergency enucleation of the left eyeball was done with an impression of malignant melanoma causing an intractable ocular pain. Grossly, the lesion in the eyeball was rising from the choroid. On histologic examination, tumor cells formed many irregular, small gland-like structures. The tumor cells showed alcian blue-positive mucin in the cytoplasm and glandular lumens and were positive for CEA. Chest CT scan was performed postoperatively and showed a huge mass in the left lower lobe and multiple nodular opacities in both lung fields. Bronchoscopic biopsy revealed moderately differentiated adenocarcinoma similar to that of the eyeball.


Subject(s)
Humans , Male , Middle Aged , Adenocarcinoma , Biopsy , Choroid , Cytoplasm , Emergencies , Lung Neoplasms , Lung , Magnetic Resonance Imaging , Melanoma , Mucins , Neoplasm Metastasis , Ophthalmology , Pleural Cavity , Pleural Effusion , Radiography, Thoracic , Retina , Tomography, X-Ray Computed , Visual Acuity
13.
Journal of the Korean Ophthalmological Society ; : 1866-1876, 1999.
Article in Korean | WPRIM | ID: wpr-70495

ABSTRACT

Fluorescein angiography (FAG) has been widely used in the diagnostic evaluation of choroidal tumors. Indocyanine green angiography (ICGA), which permits better visualization of choroidal vasculature than FAG, has been recently introduced into clinical practice. FAG and ICGA of 13 patients with choroidal tumors were assessed. These included 4 patients with choroidal nevus,4 with malignant melanoma, 2 with metastatic choroidal tumor,and 3 with choroidal hemangioma. In choroidal nevus, ICGA showed persistent hypofluorescence with clear delineation of the lesion in the late phase. Characteristic fluorescein angiographic feature of choroidal melanoma was hyperfluorescence in the late phase. However, the fluorescence of melanoma varied from hypo-,to hyperfluores- cent in the late phase of the ICGA. In choroidal metastatic tumor, FAG showed the typical pinpoint hyperfluorescence in the early phase and the diffuse leakage with serous detachment in the late phase. ICGA showed the hypofluo- rescence throughout the whole phases. In choroidal hemangioma, FAG and ICGA showed complete dye filling of the hemangioma with more denser hyperfluorescence in the early phase than in the late phase. In all patients, the lesion was better defined on the ICGA than on the FAG. This study suggests that ICGA combined with FAG may be useful in differentiating various choroidal tumors.


Subject(s)
Humans , Angiography , Choroid , Fluorescein Angiography , Fluorescein , Fluorescence , Hemangioma , Indocyanine Green , Melanoma , Nevus
SELECTION OF CITATIONS
SEARCH DETAIL